Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | DDB1 | Q16531 | 4/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 4/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 2/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4143470 | 0.87 | KDM4E (0.51) | KDM4ESMN1; SMN2CYP1A2DDB1CRBN | |
| SCHEMBL5313782 | 0.87 | KDM4E (0.51) | KDM4ESMN1; SMN2CYP1A2DDB1CRBN | |
| SCHEMBL4143472 | 0.87 | KDM4E (0.51) | KDM4ESMN1; SMN2CYP1A2DDB1CRBN | |
| SCHEMBL4134781 | 0.85 | DDB1 (0.40) | KDM4ESMN1; SMN2CYP1A2DDB1CRBN | |
| SCHEMBL4134055 | 0.82 | KDM4E (0.39) | KDM4ESMN1; SMN2CYP1A2ADRA2BMAPK1 | |
| SCHEMBL5435573 | 0.81 | SIGMAR1 (0.40) | KDM4ESMN1; SMN2CYP1A2ADRA2BMAPK1 | |
| SCHEMBL5433734 | 0.80 | SIGMAR1 (0.40) | KDM4ESMN1; SMN2CYP1A2ADRA2BMAPK1 | |
| SCHEMBL5433728 | 0.80 | SIGMAR1 (0.40) | KDM4ESMN1; SMN2CYP1A2ADRA2BMAPK1 | |
| SCHEMBL4883781 | 0.78 | BCHE (0.35) | KDM4ESMN1; SMN2DDB1CRBNBCHE | |
| SCHEMBL4136760 | 0.76 | DDB1 (0.38) | DDB1CRBNBCHECNR2PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090111760-A1 | MACROLONE COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2009-04-30 | — | — | US | disclosed |
| EP-1824869-A1 | MACROLONE COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2007-08-29 | — | — | EP | disclosed |
| WO-2006050941-A1 | MACROLONE COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2006-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090111760-A1 | MACROLONE COMPOUNDS | CYP51A1, MRPL21, MYD88 | KDM4E 3897/4885SMN1; SMN2 2560/4885CYP1A2 146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.